Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

Posted: June 22, 2022 at 2:43 am

SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, 15th July 2022 at 8:30 a.m. (Australian Eastern Standard Time).

Read more:
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

Related Posts